Ubicom Holdings. Inc. · TSE:3937
Ubicom — FY2022 Earnings Presentation
33 slides from Ubicom's earnings presentation, May 11, 2023
Slide 1: Presentation Materials For FY2022
FY2022 ended March 31, 2023 Consolidated Business Results Presentation Materials For FY2022 Ubicom Holdings, Inc. TSE Prime: 3937 May 11, 2023 Note: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated docum
Slide 2: FY2022 Highlights
FY2022 Highlights As the demand in mainly the global business is expected to continuously grow beyond assumption in the next term as well, we conducted the unplanned additional investments mainly for re-education of personnel such as cutting- edge tech talent, increase of recruitment, and expansion
Slide 3: FY2022 (P/L)
FY2022 (P/L) While looking ahead to the demand for large-scale development in the next term, we enhanced the investment for the second growth phase ahead of schedule. We actively recruited staff, mainly those who are versed in cutting-edge technologies, and executed measures for prices and exchange
Slide 4: Factors in Profit Fluctuations and Investment Status in FY2022
Factors in Profit Fluctuations and Investment Status in FY2022 In FY2022, the measures for exchange rates and prices were effective, despite the changes in exchange rates and the skyrocketing of personnel expenses. Due to the law for promoting economic security, the Philippines is attracting attenti
Slide 5: FY2022 Segment Overview: Global Business
FY2022 Segment Overview : Global Business Sales grew, thanks to significant demand. We conducted the largerst investment (including recruitment and re-education) since our company establishment. Global Business FY2021 (results) FY2022 (results) Year-on- Year [unit: million yen] Amount % to sales Amo
Slide 6: Global Business: To Grow Business by Expanding Development Resources
Global Business: To Grow Business by Expanding Development Resources In response to the most rapid increase of business inquiries since the establishment of Ubicom, we enhanced the investment in PM +AI personnel recruitment, education, and re-education. Mid-level PM engineer Mid-level engineer Young
Slide 7: Global Business: Advancement of Business Model
Global Business: Advancement of Business Model Generate pillar clients and high profitability through flexible offshore/onsite development Definition of pillar clients: Constant clients that are market leaders in each field with sales scale of several 100 million yen Establishment of Offshore (our d
Slide 8: Global Business: Promote "GO GLOBAL" Strategy
Global Business: Promote “GO GLOBAL” Strategy To strengthen business strategies with an eye on the global market (1) Promote global M&A, investment and business alliances (2) Strengthen overseas marketing (U.S./Israel) (3) AI education through alliances with companies in digitally advanced countries
Slide 9: FY2022 Segment Overview: Medical Business
FY2022 Segment Overview: Medical Business We secured high profitability and profit growth. Medical Business FY2021 (results) FY2022 (results) Year-on- Year [unit: million yen] Amount % to sales Amount % to sales Net Sales 1,484 100.0% 1,520 100.0% 102.4% Operating Income 846 57.0% 895 58.9% 105.7% •
Slide 10: Medical Business: Advancement of Business Model
Medical Business: Advancement of Business Model Expansion of highly profitable foundation with the subscription model Trend of Medical Business Performance (unit: million yen) 1,484 1,520 1,435 58.9% 1,282 1,301 57.0% 1,169 1,076 51.1% 45.4% Sales 895 Operating Income 34.9% 846 31.7% 734 Operating I
Slide 11: Medical Business: Results and Visions
Medical Business: Results and Visions After the transitional period in FY2022 (Decline in increase of clinic users mainly due to the termination of old systems of some embedded partners for the transition to their new systems), we will focus on the marketing activities to promote adoption of our sol
Slide 12: Medical Business: To Strengthen Sales Strategy
Medical Business: To Strengthen Sales Strategy Strengthening strategy to promote sales of the Mighty series Priority measures ... direct sales/consulting Sales enhancements Customer Support ... building a user community ... strengthening cost-effectiveness Marketing communication To implement the ne
Slide 13: Improvement in Life-Time Value of Customers Through the New Price Strategy
Medical Business: Improvement in Life-Time Value of Customers Through the New Price Strategy Start of a price hike with new prices for new users (the leveling model) For existing users (No. of client medical institutions in FY2022: 19,157), we plan to apply new prices at the time of switch to superi
Slide 14: Medical Business: Effects of Mainstay Solutions
Medical Business: Effects of Mainstay Solutions ■Effects of Mighty Checker (MC) for Medical Affairs *1 (1) Reduction of operation time (2) Cost reduction and profit improvement Conventional medical claims inspection Inspection (Visual) of medical claims after introducing MC Inspection cost 100% Redu
Slide 15: Launch of the top-of-the-line product Mighty QUBE Hybrid
Medical Business: Launch of the top-of-the-line product "Mighty QUBE Hybrid Official launch of the Mighty QUBE Hybrid (October 2022) Real-time checking system Mighty QUBE Hybrid Features Compatible with Medical Doctors’ Workstyle Reform 2024 Hybrid model compatible with cloud and on-premise syst
Slide 16: Medical Business: Value Chain of Core Solutions
Medical Business: Value Chain of Core Solutions Medical Workload Time-saving Time-saving safety reduction Workload Improvement Cost Improvement reduction in revenues reduction in revenues Electronic chart-linked system Medical claims checking system Assessment and denial information Reduction of the
Slide 17: Concept of Development of a System for Giving Solutions to Medical Institutions
Medical Business: Concept of Development of a System for Giving Solutions to Medical Institutions ICT and AI Shortage of Increase Tightening of Declining screening of human resources of clinics due to the declining birthrate medical claims birthrate Collapse of Issues with social Significant Personn
Slide 18: Comprehensive Solutions of Mighty QUBE Hybrid
Medical Business: Comprehensive Solutions of “Mighty QUBE Hybrid” Medical service section Pharmaceutical section To check insurance-covered diseases for pharmaceutical products, examinations, etc. Orders for prescriptions from doctors are and prescriptions for preventing incorrect screened, reducing
Slide 19: External Environment and Promotion of Business Strategy
Medical Business: External Environment and Promotion of Business Strategy Proceeding with marketing of medical solution/platform concept in line with medical healthcare DX policy, as well as preparations for business qualification with an eye on the medical platform business. ■External environment s
Slide 20: Development of an Insurance Knowledge Platform
Development of an Insurance Knowledge Platform ■Progress of projects under negotiation ・We are negotiating with a total of 7 life insurance companies out of about 50 companies in the life insurance market. With 3 companies, we are proceeding with PoC for installation by the end of 2023. ・In addition
Slide 21: Medical Domain: Growth Potential of each Solution
Medical Domain: Growth Potential of each Solution To promote further improvement of average spending per customer and recurring revenue earning capability through up-selling, cross-selling, and direct sales New Medical Platform Insurance Knowledge Platform Mighty Checker Cloud SonaM GP margin of Mig
Slide 22: Target Market Size for Medical Platforms
Target Market Size for Medical Platforms We aim to become the No. 1 platform in the niche medical field by leveraging our position as the market leader in DX solutions focused on medical institutions. New (domestic and overseas) Insurance Strategic Medical companies Markets institutions Insurance Kn
Slide 23: Platform Utilization Strategy (Medium/Long-term Vision)
Medical Platform Utilization Strategy (Medium/Long-term Vision) To create more new markets through strategies to enclose the user community (potential market size: 300 billion yen*) *surveyed by our company ・Conversion of sales staff to consultants New market ・Medical engineer training Creation ・Str
Slide 24: Promotion of M&A strategy based on the results of acquisition of subsidiaries
Promotion of M&A strategy based on the results of acquisition of subsidiaries We aim to actualize new M&A that would contribute to our platformer strategy, by utilizing the know-how of post-merger integration (PMI) for medical business. ■Successful cases of M&A: Variation in results of medical busin
Slide 25: Major Releases and Topics in FY2022
Major Releases and Topics in FY2022 Conclusion of a memorandum for expanding the global business On February 10, 2023, the President Ferdinand Marcos of the Philippines officially visited Japan, and a ceremony for signing business agreements was held. At that ceremony, we concluded a memorandum for
Slide 26: Major Releases and Topics in FY2022
Major Releases and Topics in FY2022 Global Business ・Conclusion of a memorandum related to AI solutions and personnel development with SIXAI in Israel ➡ We will continue collaboration with global partners based on the “GO GLOBAL Strategy.” Medical Business ・Launch of the top-of-the-line product “Mig
Slide 27: Earnings Forecast for FY2023
Earnings Forecast for FY2023 As we continue to make investment for the second growth phase (the investment collection phase), operating and ordinary incomes are expected to grow over 30%, while absorbing the constant investment in human resources for cutting-edge technologies. Sales are projected to
Slide 28: Promotion of the 2nd Growth Phase
Promotion of the 2nd Growth Phase We will execute a growth strategy To maximize the synergy between the existing business and M&A, and promote the development in line with the global situation trends of new recurring-revenue/SaaS model ・Medical field Themes of the ・Pillar clients: + 20 companies ・Gl
Slide 29: ESG: Towards Sustainable Development of Business, Society & Customer
ESG: Towards Sustainable Development of Business, Society & Customer ■Global Business ・DX Support (Business process reforms for clients through advanced technology support such as AI/Analytics/Automation/Cloud) ・Improvement of Japan’s global competitiveness through globalization support for domestic
Slide 30: Dividend for FY2022
Dividend for FY2022 As we have established a robust base for revenues thanks to the recent strong demand, we are paying a term-end dividend of 11.00 yen/share, up 2 yen/share from the previous fiscal year. Fiscal year FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 Annual dividend 0 5 5 7 9 11 Maximizatio
Slide 31: Company Overview
Company Overview ■Company name: Ubicom Holdings, Inc. (TSE Prime: 3937) ■Strategic industry: Medical, Financial/Public, Automotive, Manufacturing/Robotics, etc. ■Our Business: Global Business Dedicated in solving IT resource shortage in Japan and promoting DX (Digital Transformation), through provid
Slide 32: Cautionary Note on Forward Looking Statements
Cautionary Note on Forward Looking Statements This material may contain forward looking statements and forecasts regarding the future outlook at the time of publication. They are subject to risks and uncertainties including, but not limited to, domestic and international economic conditions such
Slide 33: © Ubicom Holdings, Inc.
© Ubicom Holdings, Inc.